IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management V, LLC

Q2 2022 Holdings

Filed 2022-08-12 | 14 holdings | $34.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics, Inc.(ACRS)COM00461U105$17.6M1,258,24351.6%
Compass Therapeutics, Inc.(CMPX)COM20454B104$11.7M4,400,00034.3%
Adagio Therapeutics, Inc.(IVVD)COM00534A102$4.7M1,431,82613.8%
Pardes Biosciences IncCOM69945Q105$28.9K9,400,5150.1%
Theseus Pharmaceuticals, Inc.COM88369M101$18.4K3,335,3460.1%
Somalogic, Inc.(SLGCUSD)COM CL A83444K105$15.9K3,516,4720.0%
Hims & Hers Health, Inc.(HIMS)COM CL A433000106$15.0K3,319,7860.0%
Kinnate Biopharma Inc.COM49705R105$11.0K875,0010.0%
Adicet Bio, Inc.(TORCEUR)COM007002108$9.9K680,0000.0%
Gemini Therapeutics, Inc.COM36870G105$4.1K2,435,1250.0%
Quantum-Si Incorporated(QSI)COM CL A74765K105$2.1K924,3790.0%
Enanta Pharmaceuticals, Inc.(ENTA)COM29251M106$2.0K42,2500.0%
23andMe Holding Co.COM CL A90138Q108$1.0K406,9130.0%
Pharvaris N.V.(PHVS)COMN69605108$75534,1420.0%